Design and synthesis of chroman derivatives with dual anti-breast cancer and antiepileptic activities

References

• ViswasKCSolomonRLeeHTrivediPDesign, synthesis and biological evaluation of some isatin-linked chalcones as novel anti-breast cancer agents: a molecular hybridization approachBiomed Prev Nutr201334325330
   Google Scholar
• KoufakiMKiziridiCAlexiXAlexisMNDesign and synthesis of novel neuroprotective 1,2 dithiolane/chroman hybridsBioorg Med Chem200917176432644119647438
   PubMed Web of Science ®Google Scholar
• KanbeYKimMHNishimotoMDiscovery of thiochroman and chroman derivatives as pure antiestrogens and their structure-activity relationshipBioorg Med Chem200614144803481916580210
   PubMed Web of Science ®Google Scholar
• LeeHLeeKJungJKChoJTheodorakisEASynthesis and evaluation of 6-hydroxy-7-methoxy-4-chromanone- and chroman-2-carboxamides as antioxidantsBioorg Med Chem Lett200515112745274815911250
   PubMed Web of Science ®Google Scholar
• KrausGAMengwasserJMauryWOhCSynthesis of chroman aldehydes that inhibit HIVBioorg Med Chem Lett20112151399140121306897
   PubMed Web of Science ®Google Scholar
• GuptaADwivedyAKeshriGRapid synthesis of 4-benzylidene and 4-[bis-(4-methoxyphenyl)-methylene-2-substituted phenyl-benzopyrans as potential selective estrogen receptor modulators (SERMs) using McMurry coupling reactionBioorg Med Chem Lett200616236006601216979337
   PubMed Web of Science ®Google Scholar
• ReddyBVSDivyaBSwainaMRaoTPYadavJSVishnu VardhanMVA domino Knoevenagel hetero-Diels-Alder reaction for the synthesis of polycyclic chromene derivatives and evaluation of their cytotoxicityBioorg Med Chem Lett20122251995199922330634
   PubMed Web of Science ®Google Scholar
• WangDChuangHCWengSCα-Tocopheryl succinate as a scaffold to develop potent inhibitors of breast cancer cell adhesionJ Med Chem200952185642564819708661
   PubMed Web of Science ®Google Scholar
• LalJClinical pharmacokinetics and interaction of centchroman – a mini reviewContraception201081427528020227542
   PubMed Web of Science ®Google Scholar
• LiXRebeccaFXiaokeHDiscovery of a novel drug KBU2046 that inhibits conversion of human prostate cancer to a metastatic phenotypeCancer Prev Res20103B58
   Google Scholar
• ChenCLLevineARaoAClinical pharmacokinetics of the CD19 receptor-directed tyrosine kinase inhibitor B43-genistein in patients with B-lineage lymphoid malignanciesJ Clin Pharmacol199939121248125510586390
   PubMed Web of Science ®Google Scholar
• KavithaPCharyMRSingavarapuBVVAReddyKLSynthesis, characterization, biological activity and DNA cleavage studies of tridentate Schiff bases and their Co(II) complexesJ Saudi Chem Soc20162016980
   Web of Science ®Google Scholar
• CollinsIJonesAMDiversity-oriented synthetic strategies applied to cancer chemical biology and drug discoveryMolecules20141911172211725525350364
   PubMed Web of Science ®Google Scholar
• BellGSSanderJWThe epidemiology of epilepsy: the size of the problemSeizure200211suppl A30631412185766
   PubMedGoogle Scholar
• BhatMASiddiquiNKhanSASynthesis of novel 3-(4-acetyl-5h/methyl-5-substitutedPhenyl-4,5-dihydro-1,3,4-oxadiazol-2-yl)-2h-chromen-2-ones As potential anticonvulsant agentsActa Pol Pharm200865223523918666431
   PubMed Web of Science ®Google Scholar
• KumarNChauhanLSSynthesis and anticonvulsant activity of some flavones incorporated hydrazide derivativesInt J Pharm Clin Res201574317322
   Google Scholar
• VermaMPandeyaSNSinghKNStablesJPAnticonvulsant activity of Schiff bases of isatin derivativesActa Pharm2004541495615050044
   PubMedGoogle Scholar
• El-AzabASElTahirKEDesign and synthesis of novel 7-aminoquinazoline derivatives: antitumor and anticonvulsant activitiesBioorg Med Chem Lett20122251879188522326394
   PubMed Web of Science ®Google Scholar
• NelsonMYangMDowleAAThomasJRBrackenburyWJThe sodium channel-blocking antiepileptic drug phenytoin inhibits breast tumour growth and metastasisMol Cancer2015141325623198
   PubMed Web of Science ®Google Scholar
• KersICsjernyikGMacsariIStructure and activity relationship in the (S)-N-chroman-3-ylcarboxamide series of voltage-gated sodium channel blockersBioorg Med Chem Lett201222175618562422832315
   PubMed Web of Science ®Google Scholar
• RawatPVermaSMSynthesis and pharmacological evaluation of 6-hydroxy-2,5,7,8-tetramethyl-N′-(2-oxoindolin-3-ylidene)chroman-2-carbohydrazide derivatives as antimicrobial agentsJ Chem Pharm Res201683149154
   Google Scholar
• HyattJAConvenient preparation of 2,7,8-trimethyl-6-hydroxychroman-2-carboxylic Acid (Ɣ-Trolox)Synth Commun2008381814
   Web of Science ®Google Scholar
• SkehanPStorengRScudieroDNew colorimetric cytotoxicity assay for anticancer-drug screeningJ Natl Cancer Inst19908213110711122359136
   PubMed Web of Science ®Google Scholar
• KrallRLPenryJKWhiteBGKupferbergHJSwinyardEAAntiepileptic drug development: II. Anticonvulsant drug screeningEpilepsia1978194409428699894
   PubMed Web of Science ®Google Scholar
• PorterRJCereghinoJJGladdingGDAntiepileptic drug development programCleve Clin Q19845122933056380818
   PubMedGoogle Scholar
• DunhamNWMiyaTSA note on a simple apparatus for detecting neurological deficit in rats and miceJ Am Pharm Assoc1957463208209
   Google Scholar
• MalikSAhujaPSahuKKhanSADesign and synthesis of new of 3-(benzo[d]isoxazol-3-yl)-1-substituted pyrrolidine-2, 5-dione derivatives as anticonvulsantsEur J Med Chem201484425025014748
   PubMed Web of Science ®Google Scholar
• KoufakiMKiziridiCPapazafiriPSynthesis and biological evaluation of benzopyran analogues bearing class III antiarrhythmic pharmacophoresBioorg Med Chem200614196666667816782345
   PubMed Web of Science ®Google Scholar
• LopezGVBlancoFHernandezPSecond generation of α-tocopherol analogs-nitric oxide donors: synthesis, physicochemical, and biological characterizationBioorg Med Chem200715186262627217627828
   PubMed Web of Science ®Google Scholar
• FangYSunCLiuDWangSQuanZSynthesis and anticonvulsant activity evaluation of 3-alkoxy-4-(4-(hexyloxy/heptyloxy)phenyl)-4H-1,2,4–triazoleIran J Pharm Res2015141778725561914
   PubMed Web of Science ®Google Scholar